A rare but fatal non-occlusive bowel ischemic disease, phlebosclerotic colitis is often delayed in diagnosis as it is mostly presented as chronic abdominal pain or diarrhea, which are nonspecific symptoms. Its diagnosis mainly relies on linear calcification of the mesenteric vein on radiographic examination and dark-purple discolorations of the mucosa in colonoscopic findings. The cause and pathogenesis of the disease have not been confirmed, but since most of the cases are Asian and many of them have taken herbal medicine, the correlation between phlebosclerotic colitis and herbal medicine has drawn increasing attention. Discontinuation of herbal medicine and conservative treatment are the first-line therapy for phlebosclerotic colitis, and surgical intervention is recommended for patients with severe complications, including perforation, intestinal obstruction, hemorrhage, and persistent or recurrent symptoms after conservative treatment.
We presented a 48-year-old female with abdominal pain for up to 11 years. Esophagogastroduodenoscopy showed a gastric ulcer and reflux esophagitis. After administration of high dose H2-receptor antagonist, high dose proton pump inhibitor, musculotropic spasmolytic and anti-foaming agent, abdominal pain was not alleviated but deteriorating. Colonoscopy showed dark-purple discolorations of the mucosa and engorged veins distributed from the ascending colon to the cecum. Phlebosclerotic colitis was diagnosed with abdominal CT scan, which revealed multiple linear calcifications of the superior mesenteric vein and colon wall thickening. As indicated by her medication history, the patient had long-term oral intake of herbal medicine for 20 years. With conservative treatment and discontinuation of herbal medicine, her condition became stable enough for outpatient follow-up. This case report should help remind primary physicians to consider the rare but potentially fatal phlebosclerotic colitis for patient with chronic abdominal pain, especially those who are taking herbal medicine.